im Fokus

PPC and patient outcome (EN)

Livestream bis

Post-operative pulmonary Complication and Perioperative Patient Outcome in abdominal Surgery

Für Zugriff auf on demand Inhalte brauchen Sie ein FomF Konto.

Gerneral informations

  • This Webinar is provided free of charge. To watch this session please click on «Login» then log in with your FomF-account. If you do not have any account yet, you can create one by clicking on «Registrieren».
     
  • By clicking the button «Termin vormerken» you will receive a reminder email 3 hours before the start of this WebUp and / or an SMS reminder 15 minutes before the start.
     
  • You can ask your questions live during this WebUp session. In order to do this please click on the four lines in the upper left corner of the player. In this menu you can submit your questions in the chat room by clicking on «Fragen» and then the speech bubbles. 
     
  • Missed a session? No problem, after just 24 hours the recording of the WebUp will be available on this page.
     
  • In order to have any technical issues about the stream, please visit our FAQ page or contact us directly: https://www.fomf.ch/FAQ

Important Information

This WebUp will be held in English / Diese Sendung wird in Englischer Sprache durchgeführt.

Content

Incidence of major postoperative pulmonary complications is approximately 5% leading to increased mortality and associated health care cost.[1-3] Hence, the public health impact is tremendous in view of the more than 300 million surgical procedures worldwide.[4, 5]
It is an urgent objective of various health care provider, patients and their families to reduce the rate of pulmonary complications after surgery. Significant progress was achieved in the field of surgical technique, perioperative processes, and patient selection but residual neuromuscular blockade remains a modifiable risk-factor for postoperative pulmonary complications.[6]

Prof. Thomas Fuchs-Buder from the Department of Anaesthesia and Critical Care, University of Lorraine in Nancy, is going to allude on possible ways of decreasing the risk posed by residual neuromuscular blockade and is going to evaluate the evidence regarding patient outcome.

References

[1] Kirmeier E et al. Lancet Respir Med 2019; 7:129–40 
[2] Dimick JB et al. J Am Coll Surg 2004; 199:531–7 
[3] Freundlich RE et al. Anesth Analg 2018; 127:55–62 
[4] Meara JG et al. Int J Obstet Anesth 2016; 25:75–8 
[5] Nepogodiev D et al. Lancet 2019; 393:401 
[6] Grosse-Sundrup M et al. BMJ 2012; 345:e6329

 

In cooperation with

 

Logo MSD

Moderator

Profile picture for user 00069476

Prof. Dr. Stefan Mönig

Chirurgie

Referent/innen

Profile picture for user 00069475

Prof. Dr. Thomas Fuchs-Buder

Anästhesiologie